Fundz

Zentalis Pharmaceuticals Appoints New CEO and Chief Medical Officer

PUBLIC · ZNTLNov 15, 2024

Position

Chief Medical Officer

Company

Zentalis Pharmaceuticals

Ingmar Bruns
ibruns@zentalis.com
San DiegoBiotechnologyHealthcareMedicalTherapeuticsPharmaceuticalresearch

Description

Zentalis Pharmaceuticals is making changes to its executive team, with the appointment of a new CEO and chief medical officer. Julie Eastland, former CEO of Merck-acquired Harpoon Therapeutics, will take over as CEO, while experienced oncology executive Ingmar Bruns, M.D., Ph.D., has been selected as the new chief medical officer.

Quick answer

Zentalis Pharmaceuticals Appoints New CEO and Chief Medical Officer (November 15, 2024). Zentalis Pharmaceuticals is based in San Diego, California, United States.

What did Zentalis Pharmaceuticals announce on November 15, 2024?
Zentalis Pharmaceuticals is making changes to its executive team, with the appointment of a new CEO and chief medical officer. Julie Eastland, former CEO of Merck-acquired Harpoon Therapeutics, will take over as CEO, while experienced oncology executive Ingmar Bruns, M.D., Ph.D., has been selected as the new chief medical officer.
What does Zentalis Pharmaceuticals do?
Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant...
Where is Zentalis Pharmaceuticals based?
Zentalis Pharmaceuticals is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
NRx Pharmaceuticals (November 18, 2024), Faeth Therapeutics (November 22, 2024), Azora Therapeutics, Inc. (DE) (November 5, 2024) and ALX Oncology (November 14, 2024) also announced leadership changes within 45 days of Zentalis Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Medical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Zentalis Pharmaceuticals, and when

A new leader at Zentalis Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Zentalis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zentalis Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zentalis Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zentalis Pharmaceuticals

Location

10275 Science Center Dr

San Diego, California, United States

About

Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zentalis Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Aron
Senior decision-maker at this company
••••••••@••••••••

See Aron's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Zentalis Pharmaceuticals's next move

Learn about Strategic plan

Zentalis Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.